DTI-SNNFRA: Drug-Target interaction prediction by shared nearest
  neighbors and fuzzy-rough approximation
  In-silico prediction of repurposable drugs is an effective drug discovery
strategy that supplements de-nevo drug discovery from scratch. Reduced
development time, less cost and absence of severe side effects are significant
advantages of using drug repositioning. Most recent and most advanced
artificial intelligence (AI) approaches have boosted drug repurposing in terms
of throughput and accuracy enormously. However, with the growing number of
drugs, targets and their massive interactions produce imbalanced data which may
not be suitable as input to the classification model directly. Here, we have
proposed DTI-SNNFRA, a framework for predicting drug-target interaction (DTI),
based on shared nearest neighbour (SNN) and fuzzy-rough approximation (FRA). It
uses sampling techniques to collectively reduce the vast search space covering
the available drugs, targets and millions of interactions between them.
DTI-SNNFRA operates in two stages: first, it uses SNN followed by a
partitioning clustering for sampling the search space. Next, it computes the
degree of fuzzy-rough approximations and proper degree threshold selection for
the negative samples' undersampling from all possible interaction pairs between
drugs and targets obtained in the first stage. Finally, classification is
performed using the positive and selected negative samples. We have evaluated
the efficacy of DTI-SNNFRA using AUC (Area under ROC Curve), Geometric Mean,
and F1 Score. The model performs exceptionally well with a high prediction
score of 0.95 for ROC-AUC. The predicted drug-target interactions are validated
through an existing drug-target database (Connectivity Map (Cmap)).
